One E-Commerce Corp. (ONCE) Subsidiary Signs Alliance and Service Agreement with Progenitor Cell Therapy
Today, One E-Commerce Corp. wholly-owned subsidiary, Islet Sciences, Inc. a development-stage biotech firm with key intellectual property in transplantation therapy for insulin-dependent diabetics, reported signing an important services agreement with wholly-owned subsidiary of leading custom-tailored cell therapy developer/manufacturer NeoStem Inc., Progenitor Cell Therapy. Progenitor provides complete cGMP-compliant manufacturing capabilities and consulting services which allow for supreme mastery over development and commercialization aspects related to pioneering new therapies. Progenitor delivers full-spectrum support covering all aspects of the process from early infancy in product development, through to end-phase operations like manufacturing, storage and transportation of cell products. This key agreement will see…